MedTrace Logo

Trial on Vascular Inflammation in Atopic Dermatitis

NCT02926807 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2018-12-19

No results posted yet for this study

Summary

A total of 30 subjects with moderate to severe atopic dermatitis. Thirty subjects without AD matched for sex, age and coronary artery disease risk factor with the AD subjects will also be included. All subjects will undergo the following imaging procedures: a 18FDG-PET to quantify vascular inflammation in the ascending aorta and carotids and a MDCT to calculate the Agatston score. Skin and blood biomarkers will also be assessed.

Conditions

Interventions

OTHER

FDG-PET Scan

a 18FDG-PET to quantify vascular inflammation

OTHER

MDCT

a MDCT to calculate the Agatston score

OTHER

biopsy and blood collection

biopsy and blood collection to assess biomarkers

Sponsors & Collaborators

Principal Investigators

  • Innovaderm Research clinical site · Innovaderm Research clinical site

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02926807 on ClinicalTrials.gov